These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24560772)

  • 1. Activation of β-catenin by inhibitors of glycogen synthase kinase-3 ameliorates cisplatin-induced cytotoxicity and pro-inflammatory cytokine expression in HEI-OC1 cells.
    Kim SJ; Lim JY; Lee JN; Choe SK; Kim YI; Song SR; Cho M; So HS; Park R
    Toxicology; 2014 Jun; 320():74-82. PubMed ID: 24560772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective GSK-3beta inhibitors attenuate the cisplatin-induced cytotoxicity of auditory cells.
    Park HJ; Kim HJ; Bae GS; Seo SW; Kim DY; Jung WS; Kim MS; Song MY; Kim EK; Kwon KB; Hwang SY; Song HJ; Park CS; Park RK; Chong MS; Park SJ
    Hear Res; 2009 Nov; 257(1-2):53-62. PubMed ID: 19666099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erdosteine protects HEI-OC1 auditory cells from cisplatin toxicity through suppression of inflammatory cytokines and induction of Nrf2 target proteins.
    Kim SJ; Park C; Lee JN; Lim H; Hong GY; Moon SK; Lim DJ; Choe SK; Park R
    Toxicol Appl Pharmacol; 2015 Oct; 288(2):192-202. PubMed ID: 26193055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycogen synthase kinase-3 beta inhibitor suppresses Porphyromonas gingivalis lipopolysaccharide-induced CD40 expression by inhibiting nuclear factor-kappa B activation in mouse osteoblasts.
    Die L; Yan P; Jun Jiang Z; Min Hua T; Cai W; Xing L
    Mol Immunol; 2012 Aug; 52(1):38-49. PubMed ID: 22580404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-lipoic acid protects against cisplatin-induced ototoxicity via the regulation of MAPKs and proinflammatory cytokines.
    Kim J; Cho HJ; Sagong B; Kim SJ; Lee JT; So HS; Lee IK; Kim UK; Lee KY; Choo YS
    Biochem Biophys Res Commun; 2014 Jun; 449(2):183-9. PubMed ID: 24796665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that cisplatin-induced auditory damage is attenuated by downregulation of pro-inflammatory cytokines via Nrf2/HO-1.
    So H; Kim H; Kim Y; Kim E; Pae HO; Chung HT; Kim HJ; Kwon KB; Lee KM; Lee HY; Moon SK; Park R
    J Assoc Res Otolaryngol; 2008 Sep; 9(3):290-306. PubMed ID: 18584244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells.
    Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E
    Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective mechanism of Korean Red Ginseng in cisplatin-induced ototoxicity through attenuation of nuclear factor-κB and caspase-1 activation.
    Kim SJ; Kwak HJ; Kim DS; Choi HM; Sim JE; Kim SH; Um JY; Hong SH
    Mol Med Rep; 2015 Jul; 12(1):315-22. PubMed ID: 25738645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proapoptotic effects of NF-kappaB on cisplatin-induced cell death in auditory cell line.
    Chung WH; Boo SH; Chung MK; Lee HS; Cho YS; Hong SH
    Acta Otolaryngol; 2008 Oct; 128(10):1063-70. PubMed ID: 18607991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ebselen attenuates cisplatin-induced ROS generation through Nrf2 activation in auditory cells.
    Kim SJ; Park C; Han AL; Youn MJ; Lee JH; Kim Y; Kim ES; Kim HJ; Kim JK; Lee HK; Chung SY; So H; Park R
    Hear Res; 2009 May; 251(1-2):70-82. PubMed ID: 19286452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
    Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
    Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin cytotoxicity of auditory cells requires secretions of proinflammatory cytokines via activation of ERK and NF-kappaB.
    So H; Kim H; Lee JH; Park C; Kim Y; Kim E; Kim JK; Yun KJ; Lee KM; Lee HY; Moon SK; Lim DJ; Park R
    J Assoc Res Otolaryngol; 2007 Sep; 8(3):338-55. PubMed ID: 17516123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of glycogen synthase kinase-3 in TNF-alpha-induced NF-kappaB activation and apoptosis in hepatocytes.
    Schwabe RF; Brenner DA
    Am J Physiol Gastrointest Liver Physiol; 2002 Jul; 283(1):G204-11. PubMed ID: 12065308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epicatechin protects the auditory organ by attenuating cisplatin-induced ototoxicity through inhibition of ERK.
    Lee JS; Kang SU; Hwang HS; Pyun JH; Choung YH; Kim CH
    Toxicol Lett; 2010 Dec; 199(3):308-16. PubMed ID: 20883750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF-α-mediated NF-κB survival signaling impairment by cisplatin enhances JNK activation allowing synergistic apoptosis of renal proximal tubular cells.
    Benedetti G; Fredriksson L; Herpers B; Meerman J; van de Water B; de Graauw M
    Biochem Pharmacol; 2013 Jan; 85(2):274-86. PubMed ID: 23103562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin ototoxicity involves cytokines and STAT6 signaling network.
    Kim HJ; Oh GS; Lee JH; Lyu AR; Ji HM; Lee SH; Song J; Park SJ; You YO; Sul JD; Park C; Chung SY; Moon SK; Lim DJ; So HS; Park R
    Cell Res; 2011 Jun; 21(6):944-56. PubMed ID: 21321603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel synthetic compound, 3-amino-3-(4-fluoro-phenyl)-1H-quinoline-2,4-dione, inhibits cisplatin-induced hearing loss by the suppression of reactive oxygen species: in vitro and in vivo study.
    Shin YS; Song SJ; Kang SU; Hwang HS; Choi JW; Lee BH; Jung YS; Kim CH
    Neuroscience; 2013 Mar; 232():1-12. PubMed ID: 23246618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of protein L-isoaspartyl methyltransferase expression by lithium is mediated by glycogen synthase kinase-3 inactivation and beta-catenin stabilization.
    Lamarre M; Desrosiers RR
    Neuropharmacology; 2008 Oct; 55(5):669-76. PubMed ID: 18582478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation.
    Hoeflich KP; Luo J; Rubie EA; Tsao MS; Jin O; Woodgett JR
    Nature; 2000 Jul; 406(6791):86-90. PubMed ID: 10894547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of silymarin against cisplatin-induced ototoxicity.
    Cho SI; Lee JE; Do NY
    Int J Pediatr Otorhinolaryngol; 2014 Mar; 78(3):474-8. PubMed ID: 24434130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.